New Stem Cell Production Facility Installs CompacT SelecT™
News Mar 14, 2007
The CompacT SelecT at SCS will be used to culture several different human and mouse stem cell lines to supply the world’s top pharmaceutical companies with the right quantity, as well as quality of cells in assay ready plates.
According to TAP, Compact SelecT is ideal for growing high quality stem cells because it can maintain cells in a consistent environment. The system’s action and flexible robotic arm coupled with its software ensures cells can be processed on demand and left unattended, even at night or over weekends.
Julie Kerby, Business Unit Manager at SCS explained: “Stem cells are harder to grow than most cell lines so you have to reproduce their optimum growth conditions every time. We are confident the CompacT SelecT can do this because it is based on TAP’s SelecT cell culture system, which deservedly has the reputation of being the pharma industry’s gold standard for reliable automated cell culturing.”
Phil Offin, Cell Culture Product Manager at TAP added: “We are delighted to have such a major supplier of stem cells invest in a CompacT SelecT. SCS’s astute decision will ensure top pharmas (with a SelecT) now have the flexibility to either obtain SCS’s quality assured cells on time, in their preferred format, or since CompacT SelecT and SelecT share the same sophisticated technology, they can confidently in-licence the cells to grow in house, because transferring proven production protocols will be rapid and reliable.”
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.